Harri Niinikoski
Professor, Nutrition in Medicine (Institute of Biomedicine)
hjniin@utu.fi TUCH (phone): +358-2-3130000 |
Childhood endocrinology and nutrition; inherited metabolic diseases; neonatal screening; prevention of cardiovascular risk factors.
Professor Harri Niinikoski graduated from the Medical School at the University of Turku
in 1991, where he also specialized in Pediatrics in 2000 and received
subspecialty in Pediatric Endocrinology in 2006. He defended his thesis on prevention
of cardiovascular risk factors in childhood in 1997 (The STRIP study). He did
his post-doc training at the Childhood Nutrition Research Center at the Baylor
School of Medicine, Houston, Texas, in 2001-2003. Subsequently, he worked as a
Senior Clinical Researcher and Clinical Lecturer at the Department of Pediatrics,
University of Turku, and in 2011-2015 as the Head of the Division of Pediatric
Care in Turku University Hospital. From 2015, he has been Professor of Nutrition
in Medicine
Professor Harri Niinikoski’s research interest focus on primary prevention of
cardiovascular disease, and childhood nutrition, endocrinology and metabolism.
Moreover, he has been closely involved in launching the neonatal metabolic
screening program which started in Finland in 2015.
Main research projects are 1) The STRIP study (The Special Turku coronary risk
factor Intervention Project) which started in 1990 and involved 1062 infants
which were randomized into nutrition an intervention or a control group. He is deputy P.I. in STRIP; 2) DIARA2 study which involves 317 children (217 in
Turku, 100 in Oulu) whose mothers were treated with either metformin or insulin
due to gestational diabetes. The children are now thoroughly investigated at 9
years of age; 3) LPI study. Lysinuric protein intolerance (LPI) is a rare
metabolic disease which belongs to the Finnish disease heritage. There are
approx. 50 Finnish patients who are annually studied at the Turku University
Hospital pediatric metabolic outpatient clinic; 4) Congenital
hypothyroidism study. CH has been screened in Finland since 1980, affects
1:2000 newborns and is treated with thyroxine. The outcome of the treatment of
CH is investigated in national CH study which is launched in 2018.
In 2006-2010, Harri Niinikoski worked as a full-time teacher of pediatrics at the
Department of Pediatrics, University of Turku.
- Aberrations in the early pregnancy serum metabolic profile in women with prediabetes at two years postpartum (2023)
- Metabolomics
- Aineenvaihduntataudit (2023) Lastentaudit Uusimaa Johanna, Niinikoski Harri, Isohanni Pirjo
- Association of Physical Activity with Metabolic Profile from Adolescence to Adulthood (2023)
- Scandinavian Journal of Medicine and Science in Sports
- Blood Pressure at Different Life Stages Over the Early Life Course and Intima-Media Thickness (2023)
- JAMA Pediatrics
- Comorbidity in Congenital Hypothyroidism—A Nationwide, Population-based Cohort Study (2023)
- Journal of Clinical Endocrinology and Metabolism
- Endokrinologiset sairaudet (2023) Lastentaudit Jääskeläinen Jarmo, Niinikoski Harri
- Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children (2023)
- Journal of Pediatric Gastroenterology and Nutrition
- Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum (2023)
- Acta Diabetologica
- Incidence of primary congenital hypothyroidism over 24 years in Finland (2023)
- Pediatric Research
- Lastentaudit (2023) Renko Marjo, Niinikoski Harri, Palmu Sauli
- Lihavuus (2023) Lastentaudit Niinikoski Harri, Vuorela Nina
- Metformin versus insulin for gestational diabetes: Adiposity variables and adipocytokines in offspring at age of 9 years (2023)
- Diabetes Research and Clinical Practice
- Metformin Versus Insulin for Gestational Diabetes: Cognitive and Neuropsychological Profiles of Children Aged 9 years (2023)
- Journal of Developmental and Behavioral Pediatrics
- Normaali kasvu (2023) Lastentaudit Niinikoski Harri, Saari Antti
- Nuoruusiän biologinen kehitys ja masennusriski (2023) Nuorten masennus ja interpersonaalinen terapia Karlsson Hasse, Niinikoski Harri
- Nuoruusiän syömishäiriöt (2023) Lastentaudit Ruusunen Anu, Niinikoski Harri
- Plasma calprotectin is extremely high in patients with lysinuric protein intolerance (2023)
- JIMD Reports
- Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment (2023)
- Journal of Diabetes and its Complications
- Ravinto (2023) Lastentaudit Luukkainen Päivi, Niinikoski Harri
- Sairaan lapsen hoito kotona (2023) Lastentaudit Niinikoski Harri, Palmu Sauli